Phase Ib 9cUAB30 in Early Stage Breast Cancer to Evaluate Biologic Effect

Grant

Date/time Interval

  • August 12, 2016 - September 23, 2021
  • Total Award Amount

  • 38414.00
  • Direct Costs

  • 26132.00
  • Sponsor Award Id

  • 769K753
  • Contributor

  • Ahmed Elkhanany   Investigator  
  • Catherine Parker M.D.   Investigator  
  • Drexell Boggs   Investigator  
  • Erica Stringer-Reasor M.D.   Investigator  
  • Helen Krontiras M.D.   Principal Investigator  
  • Jennifer De Los Santos   Investigator  
  • Kimberly Keene M.D.   Investigator  
  • Rachael Lancaster M.D.   Investigator